Man Group
FOLD

Man Group’s Amicus Therapeutics FOLD Stock Holding History

Man Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.7M Buy
806,484
+406,484
+102% +$5.83M 0.02% 741
2025
Q4 		$5.7M Buy
+400,000
New +$3.93M 0.01% 1044
2025
Q2 		– Sell
-1,018,301
Closed -$8.31M – 2234
2025
Q1 		$8.31M Buy
1,018,301
+962,860
+1,737% +$8.91M 0.02% 799
2024
Q4 		$522K Sell
55,441
-680,887
-92% -$7.08M ﹤0.01% 1658
2024
Q3 		$7.86M Buy
+736,328
New +$8.02M 0.02% 845
2023
Q3 		– Sell
-222,504
Closed -$2.87M – 1082
2023
Q2 		$2.79M Buy
+222,504
New +$2.64M 0.01% 1086
2023
Q1 		– Sell
-290,732
Closed -$3.55M – 2133
2022
Q4 		$3.55M Buy
290,732
+185,635
+177% +$2.09M 0.01% 959
2022
Q3 		$1.1M Buy
+105,097
New +$1.17M 0.01% 1253
2022
Q2 		– Hold
0
– – – 1844
2021
Q1 		– Sell
-213,720
Closed -$4.93M – 1899
2020
Q4 		$4.93M Sell
213,720
-296,226
-58% -$6.06M 0.02% 819
2020
Q3 		$7.2M Sell
509,946
-12,898
-2% -$188K 0.03% 623
2020
Q2 		$7.88M Buy
522,844
+288,880
+123% +$3.52M 0.04% 456
2020
Q1 		$2.16M Sell
233,964
-56,134
-19% -$534K 0.01% 852
2019
Q4 		$2.83M Buy
290,098
+20,401
+8% +$187K 0.01% 1220
2019
Q3 		$2.16M Sell
269,697
-21,664
-7% -$235K 0.01% 1219
2019
Q2 		$3.64M Buy
291,361
+156,176
+116% +$1.98M 0.01% 1078
2019
Q1 		$1.84M Sell
135,185
-11,715
-8% -$143K 0.01% 1372
2018
Q4 		$1.41M Sell
146,900
-71,886
-33% -$790K 0.01% 1346
2018
Q3 		$2.65M Buy
218,786
+180,351
+469% +$2.52M 0.01% 1298
2018
Q2 		$600K Sell
38,435
-239,243
-86% -$3.62M ﹤0.01% 1759
2018
Q1 		$4.18M Buy
+277,678
New +$4.23M 0.02% 947

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Man Group's FOLD Position: Q1 2026 in Review

Man Group increased its Amicus Therapeutics (FOLD) stake by 102% in Q1 2026, buying an estimated $5.83M and bringing the position to 806,484 shares worth $11.7M. The position accounts for 0.02% of the portfolio, ranked #741.

Man Group first reported a position in FOLD in Q1 2018 and has held it in 20 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Man Group held 806,484 shares of Amicus Therapeutics worth $11.7M as of Q1 2026.
  • Man Group bought 406,484 Amicus Therapeutics shares in Q1 2026, an estimated $5.83M.
  • Amicus Therapeutics made up 0.02% of Man Group's portfolio in Q1 2026, its #741 holding.
  • Man Group first reported a position in Amicus Therapeutics in Q1 2018 and has held it in 20 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.